Open Positions for Postdoctoral Fellows

Postdoctoral Fellowship 1: Translational research on lymphatic filariasis and onchocerciasis The Infectious Diseases Division of the Washington University School of Medicine in St. Louis has support from the Bill & Melinda Gates Foundation for research related to the elimination programs for lymphatic filariasis and onchocerciasis (see www.dolfproject.wustl.edu). We are seeking a postdoctoral fellow to perform […]
New clinical trial for treatment of LF in Cote d’Ivoire

New clinical trial for treatment of LF in Cote d’Ivoire

DOLF project studies have demonstrated the safety and superior efficacy of IDA (a triple drug regimen of ivermectin, DEC, and albendazole) for treatment of lymphatic filariasis (LF). Moxidectin is a new drug that was recently approved for treatment of onchocerciasis. It is more effective than ivermectin for long-term clearance of O. volvulus parasites from the […]

DOLF Project Ophthalmologists Publish Short Case Report

DOLF project ophthalmologists Michael Gyasi and Augustine Hong have published a short case report of a patient with ocular onchocerciasis. This includes a photo and a very interesting video with motile microfilariae in the anterior chamber of the eye (open access, see “supplements”) that people may want to use for teaching or social mobilization. Microfilarial […]
DOLF Team Collaborates for Upcoming IDA Rollout in Indonesia

DOLF Team Collaborates for Upcoming IDA Rollout in Indonesia

The DOLF team recently collaborated with the Universitas Indonesia, Jakarta and the Indonesian Ministry of Health to host a 1.5-day meeting in early February in Jakarta to discuss strategic planning for the upcoming rollout of IDA mass drug administration (MDA) in the country. The attendee list also included a representative of the Bill and Melinda […]

DOLF Laboratory Core Improves Microscopy Technology

The lab in St. Louis received an Olympus VS120-S6 microscope and slide scanner. Microscopy is essential to study the effect of drugs on adult Onchocerca volvulus worms. However, drug-related morphological changes are sometimes difficult to differentiate from age-related changes of the worms. Unfortunately, is the technical expertise to judge worms in histological nodule sections vanishing […]

DOLF Research-Roll-Out of IDA for LF Elimination in PNG (ENB)

Dr. Christopher King and his team from Case Western Reserve University and Dr. Alison Krentel from the Bruyere Research Institute in Ottawa have returned to East New Britain to continue their research. Dr. Krentel will train local staff on procedures for assessing the acceptability of the triple drug mass drug administration that was provided province-wide […]
DOLF initiates a trial of IDA triple drug treatment for Oncho

DOLF initiates a trial of IDA triple drug treatment for Oncho

DOLF researchers and staff traveled to Hohoe, Ghana in December 2019 to work with Nick Opoku’s team at the University of Health and Allied Sciences to initiate a trial of the triple drug treatment IDA in persons with onchocerciasis. This study is testing the same IDA combination (ivermectin plus DEC and albendazole) that is so […]

Two New Members Join the DOLF Team

Nicole Fetcho joined the DOLF Project in October 2019 as a Statistical Data Analyst and Data Manager. Nicole is well prepared for this work with a Master of Public Health degree (with a focus on Biostati­­stics and Epidemiology) from the Brown School of Social Work at Washington University in St. Louis. Her MPH practicum work […]

Introducing Teresa Tufte – Global Health Program Manager

New Global Health Program Manager (Operations) - The DOLF Project Teresa joins the DOLF project as the Global Health Program Manager for Operations taking over for Rachel Anderson. She joins us with two years of health care research and data analysis experience at the State of Massachusetts’s Center for Health Information and Analysis. Prior to […]
DOLF Obtains $2.4 Million to Fund Research in Papua New Guinea

DOLF Obtains $2.4 Million to Fund Research in Papua New Guinea

The DOLF project has received a 2.4 million dollar grant to support studies to assess the impact of an IDA implementation program in East New Britain province, Papua New Guinea (PNG) from the Bill & Melinda Gates Foundation . Prior DOLF studies have demonstrated the safety and efficacy of the “IDA” three-drug combination drug therapy […]